波士顿I型人工角膜长期疗效:解放军总医院经验
该回顾性病例系列纳入2011年3月至2019年9月在解放军总医院接受波士顿I型人工角膜(B-KPro type I)植入的103眼(100例),主要适应证为化学伤(59.2%)、眼外伤(25.2%)、疱疹性角膜炎(11.7%)和自身免疫病(3.9%)。术后6个月至8年视力≥10/200的比例从82.7%逐渐降至42.9%,假体保留率高,但术后并发症包括角膜融解(18.4%)和人工角膜后膜(19.4%)等。B-KPro type I是严重眼表疾病传统角膜移植预后差者的可行选择。
要点
- 术后6个月82.7%眼视力≥10/200,8年降至42.9%。
- 主要并发症包括人工角膜后膜(19.4%)和角膜融解(18.4%)。
核心结论
- 在中国患者中,B-KPro type I是严重眼表疾病且传统角膜移植预后差眼的可行选择,尤其适用于化学伤和热烧伤患者。
- 多数病例可获得并维持视力改善和高假体保留率。
研究设计与样本
- 回顾性病例系列,纳入2011年3月至2019年9月在解放军总医院接受B-KPro type I植入的103眼(100例)。
- 记录并分析视力、B-KPro type I保留率和术后并发症。
主要发现
- 主要适应证为化学伤(59.2%)、眼外伤(25.2%)、疱疹性角膜炎(11.7%)和自身免疫病(3.9%)。
- 术后视力≥10/200的比例:6个月82.7%,12个月82.8%,2年77.9%,3年72.4%,4年71.1%,5年69.4%,6年58.9%,7年56.8%,8年42.9%。
- 术前8.7%眼诊断为新发青光眼。
- 术后并发症:人工角膜后膜19.4%,角膜融解18.4%,无菌性玻璃体炎4.9%,感染性眼内炎2.9%,视网膜脱离0.9%。
临床怎么用
- 对于严重眼表疾病且传统角膜移植预后差者,可考虑B-KPro type I,尤其化学伤和热烧伤患者。
- 术后需长期随访视力及并发症,关注人工角膜后膜、角膜融解、青光眼和眼内炎等。
局限性
- 回顾性病例系列设计。
- 单中心经验。
- 原文未报告假体保留率的具体数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the long-term outcomes of Boston keratoprosthesis type I (B-KPro type I) implantation in the management of severe ocular surface disorders. METHODS: Retrospective case series. Patients who underwent B-KPro type I implantation at the People's Liberation Army General Hospital were enrolled between March 2011 and September 2019. Data regarding visual acuity (VA), B-KPro type I retention and postoperative complications were recorded and analysed. RESULTS: A total of 103 eyes of 100 patients who underwent B-KPro type I implantation were included. The main indications were chemical burn (59.2%), ocular trauma (25.2%), herpetic keratitis (11.7%) and autoimmune diseases (3.9%). The percentage of eyes with postoperative VA of 10/200 or better was 82.7% at 6 months, 82.8% at 12 months, 77.9% at 2 years, 72.4% at 3 years, 71.1% at 4 years, 69.4% at 5 years, 58.9% at 6 years, 56.8% at 7 years and 42.9% at 8 years. Preoperatively, 8.7% eyes were diagnosed with new-onset glaucoma. Retroprosthetic membrane formation occurred in 19.4% eye. Corneal melting occurred in 18.4% eyes. Sterile vitritis was diagnosed in 4.9% eyes and infectious endophthalmitis in 2.9% eyes. Retinal detachment occurred in 0.9% eyes. CONCLUSIONS: In a Chinese patient group, B-KPro type I is a viable option for treating severe ocular surface disorders in eyes where conventional keratoplasty would have a poor prognosis, especially in patients with chemical and thermal burns. Improved visual outcomes and high retention rate can be achieved and maintained in most cases.
引用
- Wang LQ, Wu TY, Chen XN, et al. Long-term outcomes of Boston keratoprosthesis type I: the Chinese People's Liberation Army General Hospital experience. Br J Ophthalmol. 2021. PMID: 33674425. doi:10.1136/bjophthalmol-2019-315617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。